[13]曹达龙，叶定伟.免疫治疗在膀胱癌中的最新研究进展和未来展望[J].中国癌症杂志，2018，7(12)：90-92.

    [14] Zhou T C，Sankin A I，Porcelli S A，et al.A review of the PD-1/PD-L1 checkpoint in bladder cancer：From mediator of immune escape to target for treatment11MPS is an investor in and consultant for Urogen.SAP is consultant and advisor for Vaccinex.The remaining authors have nothing to disclose[J].Urologic Oncology Seminars & Original Investigations ......